BCM
IONS icon

Boone Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Boone Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.2M Buy
519,977
+19,455
+4% +$1.46M 9.64% 4
2026
Q1 		$37.6M Buy
500,522
+82,689
+20% +$6.53M 11.51% 2
2025
Q4 		$33.1M Hold
417,833
– – 10.37% 3
2025
Q3 		$27.3M Buy
+417,833
New +$20.4M 8.96% 3

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Boone Capital Management's IONS Position: Q2 2026 in Review

Boone Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 3.9% in Q2 2026, buying an estimated $1.46M and bringing the position to 519,977 shares worth $41.2M. The position accounts for 9.64% of the portfolio, ranked #4.

Boone Capital Management first reported a position in IONS in Q3 2025 and has held it in 4 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Boone Capital Management held 519,977 shares of Ionis Pharmaceuticals worth $41.2M as of Q2 2026.
  • Boone Capital Management bought 19,455 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.46M.
  • Ionis Pharmaceuticals made up 9.64% of Boone Capital Management's portfolio in Q2 2026, its #4 holding.
  • Boone Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Boone Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.